Showing 1 - 10 of 26
We study the design of provider incentives in the post-acute care setting – a high-stakes but under-studied segment of the healthcare system. We focus on long-term care hospitals (LTCHs) and the large (approximately $13,000) jump in Medicare payments they receive when a patient's stay reaches...
Persistent link: https://www.econbiz.de/10012964400
Persistent link: https://www.econbiz.de/10011613889
Government programs are often offered on an optional basis to market participants. We explore the economics of such voluntary regulation in the context of a Medicare payment reform, in which one medical provider receives a single, predetermined payment for a sequence of related healthcare...
Persistent link: https://www.econbiz.de/10012833119
Persistent link: https://www.econbiz.de/10012238003
Persistent link: https://www.econbiz.de/10012799273
Government programs are often offered on an optional basis to market participants. We explore the economics of such voluntary regulation in the context of a Medicare payment reform, in which one medical provider receives a single, predetermined payment for a sequence of related healthcare...
Persistent link: https://www.econbiz.de/10012481806
We study the design of provider incentives in the post-acute care setting - a high-stakes but under-studied segment of the healthcare system. We focus on long-term care hospitals (LTCHs) and the large (approximately $13,500) jump in Medicare payments they receive when a patient's stay reaches a...
Persistent link: https://www.econbiz.de/10012929197
Persistent link: https://www.econbiz.de/10014528578
This paper examines the implications of regulatory change for the input mix and technology choices of regulated industries. We present a simple neoclassical framework that emphasizes the change in relative factor prices associated with the regulatory change from full cost to partial cost...
Persistent link: https://www.econbiz.de/10013221986
The introduction of Medicare in 1965 was the single largest change in health insurance coverage in U.S. history. Many economists and commentators have conjectured that the introduction of Medicare may have also been an important impetus for the development of new drugs that are now commonly used...
Persistent link: https://www.econbiz.de/10013245549